Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

Market Cap	13.55B
Revenue (ttm)	5.22B
Net Income (ttm)	172.92M
Shares Out	760.85M
EPS (ttm)	0.23
PE Ratio	76.76
Forward PE	118.73
Dividend	0.06 (0.34%)
Ex-Dividend Date	Sep 25, 2025

Volume	10,706,520
Average Volume	15,721,127
Open	17.25
Previous Close	17.35
Day's Range	17.25 - 17.85
52-Week Range	10.60 - 20.37
Beta	0.32
RSI	64.42
Earnings Date	Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engage in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 5,417
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300171

Financial Performance

In 2024, SHE:300171's revenue was 5.01 billion, a decrease of -11.19% compared to the previous year's 5.64 billion. Earnings were 194.09 million, a decrease of -67.66%.